Research and Development Activities and R&D Expenditure
First written in FY2017-Q3. 33 of 34 entries say "Advanced", first in FY2017. Latest entry: FY2026.
45 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥205.248 million.」
FY2026 full-year R&D expenses of ¥205.248 million were disclosed, up from ¥175.318 million in the previous fiscal year. - FY2026-H1AdvancedAnnual report
「The Company's R&D expenses for the interim accounting period were ¥110.527 million.」
R&D expenses of ¥110.527 million were disclosed for the interim accounting period, up from ¥79.714 million in the same period of the previous fiscal year. - FY2025AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥175.318 million.」
FY2025 full-year R&D expenses of ¥175.318 million were disclosed, up from ¥130.381 million in the previous fiscal year. - FY2025-H1AdvancedAnnual report
「The Company's R&D expenses for the interim accounting period were ¥79.714 million.」
R&D expenses of ¥79.714 million were disclosed for the FY2025 interim accounting period, up from ¥63.398 million in the same period of the previous fiscal year. - FY2024AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥130.381 million.」
Full-year R&D expenses amounted to ¥130.381 million, up from ¥123.396 million in the previous fiscal year. - FY2024-Q3AdvancedAnnual report
「The Company's R&D expenses for the cumulative third quarter period were ¥96.245 million.」
R&D expenses of ¥96.245 million were disclosed for the FY2024 cumulative third quarter period. No material changes in the status of R&D activities were reported. - FY2024-Q2AdvancedAnnual report
「The Company's R&D expenses for the cumulative second quarter period were ¥63.398 million.」
R&D expenses of ¥63.398 million were disclosed for the cumulative second quarter period. No material changes in the status of R&D activities were reported. - FY2024-Q1AdvancedAnnual report
「The Company's R&D expenses for the cumulative first quarter period were ¥30.694 million.」
R&D expenses of ¥30.694 million were disclosed for the FY2024 cumulative first quarter period. No material changes in the status of R&D activities were reported. - FY2023AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥123.396 million.」
Full-year R&D expenses amounted to ¥123.396 million, up from ¥118.924 million in the previous fiscal year. - FY2023-Q3AdvancedAnnual report
「The Company's R&D expenses for the cumulative third quarter period were ¥88.398 million.」
R&D expenses of ¥88.398 million were disclosed for the FY2023 cumulative third quarter period. - FY2023-Q2AdvancedAnnual report
「The Company's R&D expenses for the cumulative second quarter period were ¥58.801 million.」
R&D expenses of ¥58.801 million were disclosed for the FY2023 cumulative second quarter period. No material changes in the status of R&D activities were reported. - FY2023-Q1AdvancedAnnual report
「The Company's R&D expenses for the cumulative first quarter period were ¥28.398 million.」
R&D expenses of ¥28.398 million were reported for the FY2023 cumulative first quarter period. No material changes in the status of R&D activities were reported. - FY2022AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥118.924 million.」
Full-year R&D expenses for new service development and feature enhancements amounted to ¥118.924 million, up from ¥104.225 million in the previous fiscal year. - FY2022-Q3AdvancedAnnual report
「The Company's R&D expenses for the cumulative third quarter period were ¥85.698 million.」
R&D expenses of ¥85.698 million were disclosed for the cumulative third quarter period. No material changes in the status of R&D activities were reported. - FY2022-Q2AdvancedAnnual report
「The Company's R&D expenses for the cumulative second quarter period were ¥56.603 million.」
R&D expenses of ¥56.603 million were disclosed for the FY2022 cumulative second quarter period. No material changes in the status of R&D activities were reported. - FY2022-Q1AdvancedAnnual report
「The Company's R&D expenses for the cumulative first quarter period were ¥28.380 million.」
R&D expenses of ¥28.380 million were disclosed for the FY2022 cumulative first quarter period. - FY2021AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥104.225 million.」
Full-year R&D expenses of ¥104.225 million for new service development and feature enhancements were disclosed. - FY2021-Q3AdvancedAnnual report
「The Company's R&D expenses for the cumulative third quarter period were ¥69.986 million.」
R&D expenses of ¥69.986 million were reported for the FY2021 cumulative third quarter period. No material changes in the status of R&D activities were reported. - FY2021-Q2AdvancedAnnual report
「The Company's R&D expenses for the cumulative second quarter period were ¥47.177 million.」
R&D expenses of ¥47.177 million were disclosed for the FY2021 cumulative second quarter period. No material changes in the status of R&D activities were reported. - FY2021-Q1AdvancedAnnual report
「The Company's R&D expenses for the cumulative first quarter period were ¥25.363 million.」
R&D expenses of ¥25.363 million were disclosed for the FY2021 cumulative first quarter period. No material changes in the status of R&D activities were reported. - FY2020AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥95.635 million.」
Annual R&D expenses for new service development and feature enhancements amounted to ¥95.635 million. - FY2020-Q3AdvancedAnnual report
「The Company's R&D expenses for the cumulative third quarter period were ¥61.820 million.」
R&D expenses of ¥61.820 million were disclosed for the cumulative third quarter period. No material changes in the status of R&D activities were reported. - FY2020-Q2AdvancedAnnual report
「The Company's R&D expenses for the cumulative second quarter period were ¥35.057 million.」
R&D expenses of ¥35.057 million were disclosed for the cumulative second quarter period. No material changes in the status of R&D activities were reported. - FY2020-Q1AdvancedAnnual report
「The Company's R&D expenses for the cumulative first quarter period were ¥16.873 million. There were no material changes in the status of the Company's R&D activities during the cumulative first quarter period.」
R&D expenses of ¥16.873 million were disclosed for the cumulative first quarter period. No material changes in the status of R&D activities were reported. - FY2019AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥63.035 million.」
Full-year R&D expenses of ¥63.035 million were disclosed. This was a decrease from ¥68.939 million in the previous fiscal year. - FY2019-Q3AdvancedAnnual report
「The Company's R&D expenses for the cumulative third quarter period were ¥43.363 million. There were no material changes in the status of the Company's R&D activities during the cumulative third quarter period.」
R&D expenses of ¥43.363 million were disclosed for the FY2019 cumulative third quarter period. No material changes in the status of R&D activities were reported. - FY2019-Q2AdvancedAnnual report
「The Company's R&D expenses for the cumulative second quarter period were ¥29.072 million. There were no material changes in the status of the Company's R&D activities during the cumulative second quarter period.」
R&D expenses of ¥29.072 million were disclosed for the cumulative second quarter period. No material changes in the status of R&D activities were reported. - FY2019-Q1AdvancedAnnual report
「The Company's R&D expenses for the cumulative first quarter period were ¥13.764 million. There were no material changes in the status of the Company's R&D activities during the cumulative first quarter period.」
R&D expenses of ¥13.764 million were reported for the FY2019 cumulative first quarter period. No material changes in the status of R&D activities were reported. - FY2018AdvancedAnnual report
「Total expenses incurred for R&D during the fiscal year were ¥68.939 million.」
Full-year R&D expenses of ¥68.939 million were reported, updated from ¥35.472 million in the previous fiscal year and ¥45.206 million for the cumulative third quarter period. - FY2018-Q3AdvancedAnnual report
「The Company's R&D expenses for the cumulative third quarter period were ¥45.206 million. There were no material changes in the status of the Company's R&D activities during the cumulative third quarter period.」
R&D expenses of ¥45.206 million were disclosed for the cumulative third quarter period. No material changes in the status of R&D activities were reported. - FY2018-Q2AdvancedAnnual report
「The Company's R&D expenses for the cumulative second quarter period were ¥29.528 million.」
R&D expenses of ¥29.528 million were reported for the cumulative second quarter period. No material changes in the status of R&D activities were reported. - FY2018-Q1AdvancedAnnual report
「The Company's research and development expenses for the three months ended [the current first quarter] were ¥14.194 million. There were no material changes in the status of the Company's research and development activities during the period.」
R&D expenses of ¥14.194 million for the quarter are disclosed. There have been no material changes in the status of R&D activities. - FY2017AdvancedAnnual report
「The Company conducts research and development to contribute to the development of various data analysis and utilization tools and to develop new services and enhance service functionality. Total research and development expenses for the fiscal year were ¥35.472 million.」
The purpose of the research and development activities was stated as developing new services and enhancing functionality, and annual research and development expenses were ¥35.472 million. - FY2017-Q3First statedAnnual report
「The Company's research and development expenses for the nine months ended [the current third quarter] were ¥22.336 million. There were no material changes in the status of the Company's research and development activities during the period.」
Research and development expenses for the cumulative period were disclosed, while there were no material changes in research and development activities.